Corcept Therapeutics Inc
NASDAQ:CORT

Watchlist Manager
Corcept Therapeutics Inc Logo
Corcept Therapeutics Inc
NASDAQ:CORT
Watchlist
Price: 70.06 USD -1.57% Market Closed
Market Cap: 7.4B USD

Wall Street
Price Targets

CORT Price Targets Summary
Corcept Therapeutics Inc

Wall Street analysts forecast CORT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CORT is 141.02 USD with a low forecast of 132.31 USD and a high forecast of 152.25 USD.

Lowest
Price Target
132.31 USD
89% Upside
Average
Price Target
141.02 USD
101% Upside
Highest
Price Target
152.25 USD
117% Upside
Corcept Therapeutics Inc Competitors:
Price Targets
002399
Shenzhen Hepalink Pharmaceutical Group Co Ltd
40% Downside
4746
Formosa Laboratories Inc
70% Upside
CONCORDBIO
Concord Biotech Ltd
8% Downside
4506
Sumitomo Pharma Co Ltd
35% Downside
SBBC
Simply Better Brands Corp
123% Upside
603456
Zhejiang Jiuzhou Pharmaceutical Co Ltd
13% Upside
MDWD
Mediwound Ltd
48% Upside
ORMP
Oramed Pharmaceuticals Inc
56% Upside

Revenue
Forecast

Revenue Estimate
Corcept Therapeutics Inc

The compound annual growth rate of Corcept Therapeutics Inc's revenue for the next 3 years is 34%.

N/A
Past Growth
34%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Corcept Therapeutics Inc

The compound annual growth rate of Corcept Therapeutics Inc's operating income for the next 3 years is 91%.

N/A
Past Growth
91%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Corcept Therapeutics Inc

The compound annual growth rate of Corcept Therapeutics Inc's net income for the next 3 years is 66%.

N/A
Past Growth
66%
Estimated Growth
Estimates Accuracy
2%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CORT's stock price target?
Price Target
141.02 USD

According to Wall Street analysts, the average 1-year price target for CORT is 141.02 USD with a low forecast of 132.31 USD and a high forecast of 152.25 USD.

What is Corcept Therapeutics Inc's Revenue forecast?
Projected CAGR
34%

The compound annual growth rate of Corcept Therapeutics Inc's revenue for the next 3 years is 34%.

What is Corcept Therapeutics Inc's Operating Income forecast?
Projected CAGR
91%

The compound annual growth rate of Corcept Therapeutics Inc's operating income for the next 3 years is 91%.

What is Corcept Therapeutics Inc's Net Income forecast?
Projected CAGR
66%

The compound annual growth rate of Corcept Therapeutics Inc's net income for the next 3 years is 66%.

Back to Top